0001144204-15-023053.txt : 20150415 0001144204-15-023053.hdr.sgml : 20150415 20150415172013 ACCESSION NUMBER: 0001144204-15-023053 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20150415 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150415 DATE AS OF CHANGE: 20150415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SKYSTAR BIO-PHARMACEUTICAL CO CENTRAL INDEX KEY: 0001076939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330901534 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34394 FILM NUMBER: 15772577 BUSINESS ADDRESS: STREET 1: RM 10601, JIEZUO PLAZA, NO. 4 STREET 2: FENGHUI ROAD SOUTH, GAOXIN DISTRICT CITY: XIAN PROVINCE STATE: F4 ZIP: 00000 BUSINESS PHONE: 407-645-4433 MAIL ADDRESS: STREET 1: RM 10601, JIEZUO PLAZA, NO. 4 STREET 2: FENGHUI ROAD SOUTH, GAOXIN DISTRICT CITY: XIAN PROVINCE STATE: F4 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: CYBER GROUP NETWORK CORP DATE OF NAME CHANGE: 20000711 8-K 1 v407411_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 15, 2015

Skystar Bio-Pharmaceutical Company

(Exact name of registrant as specified in its charter)

Nevada	001-34394	33-0901534
(State or other jurisdiction	(Commission File No.)	(IRS Employer
of incorporation)		Identification No.)

4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an

Shaanxi Province, P.R. China

(Address of principal executive offices, including Zip Code)

(8629) 8819-3188

(Registrant’s telephone number, including area code)

N/A

(Former name or former address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14c))

Item 3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On April 15, 2015, Skystar Bio-Pharmaceutical Company (the “Company”) received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that since it had not filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2014, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1). The Nasdaq notification letter does not result in the immediate delisting of the Company’s common stock, and the stock will continue to trade uninterrupted under its current trading symbol. The Company must submit a plan of compliance with the foregoing listing deficiency by no later than June 15, 2015. If its plan is approved by the Nasdaq staff, the Company may be eligible for a listing exception of up to 180 calendar days (or until October 12, 2015) to regain compliance. If the Nasdaq staff concludes that the Company will not be able to cure the deficiency, or if the Company determines not to submit the required materials or make the required representations, the Company's common stock will be subject to delisting by Nasdaq. The foregoing description of the Nasdaq notification is qualified in its entirety by the text of such notification a copy of which is filed as exhibit to this filing.

Certain statements in this report that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995), include, among others, the Company’s expectations relating to the completion of the 2014 audit and filing of the 2014 Annual Report. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors, many of which are outside of the Company’s control, that could cause actual results to materially differ from such statements. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. The Company disclaims any intention to, and undertake no obligation to, update or revise any forward-looking statement.

Item 8.01

Other Events

On April 15, 2015, the Company issued a press release relating to the foregoing event, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits.

99.1

Press release.

99.2

Nasdaq Notification letter dated April 15, 2015.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 15, 2015

	Skystar Bio-Pharmaceutical Company

	By:	Bing Mei
		Bing Mei, Chief Financial Officer

EX-99.1 2 v407411_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF NASDAQ NON-COMPLIANCE LETTER DUE TO DELAY IN FILING FORM 10-K

Xi’an, China, April 15, 2015 – Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that the Company received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that since it had not filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2014, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1). The Nasdaq notification letter does not result in the immediate delisting of the Company’s common stock, and the stock will continue to trade uninterrupted under its current trading symbol.

The Company must submit a plan of compliance with the foregoing listing deficiency by no later than June 15, 2015 (the “Plan of Compliance Deadline”). If its plan is approved by the Nasdaq staff, the Company may be eligible for a listing exception of up to 180 calendar days or until October 12, 2015 to regain compliance. If the Nasdaq staff concludes that the Company will not be able to cure the deficiency, or if the Company determines not to submit the required materials or make the required representations, the Company's common stock will be subject to delisting by Nasdaq.

The Company expects the completion of the 2014 audit and filing of the 2014 Annual Report by the end of May 2015, but in no event later than the Plan of Compliance Deadline.

About Skystar Bio-Pharmaceutical Company

Skystar is a China-based developer, manufacturer and distributor of veterinary healthcare and medical care products. Skystar has four product lines: veterinary medicines, probiotics, vaccines and feed additives formulated and packaged in house across several modern manufacturing and distributions facilities. Skystar's distribution network includes almost 3,000 distribution agents of which 360 are franchised stores with exclusivity agreements covering 29 provinces throughout China. For additional information, please visit http://www.skystarbio-pharmaceutical.com.

Safe Harbor Statements

Statements contained in this press release not relating to historical facts are forward-looking statements that are intended to fall within the safe harbor rule under the Private Securities Litigation Reform Act of 1995. All forward-looking statements included herein are based upon information available to the Company as of the date hereof and, except as is expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason. To the extent that any statements made here are not historical, these statements are essentially forward-looking. The Company uses words and phrases such as "guidance," "forecasted," "projects," "is expected," "remain confident," "will" and/or similar expressions to identify forward-looking statements in this press release. Undue reliance should not be placed on forward-looking information. The Company may also make written or oral forward-looking statements in its periodic reports filed with the U.S. Securities and Exchange Commission and other written materials and in oral statements made by its officers, directors or employees to third parties. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the Company’s ability to submit a plan of compliance that will be approved by the Nasdaq staff, the Company’s ability to complete the 2014 audit and filing of the 2014 Annual Report on Form 10-K within the projected timeframe, its ability to maintain listing of its securities on Nasdaq, the Company’s ability to properly execute our business model, to address price and demand volatility, to counter seasonal fluctuations, to attract and retain management and operational personnel, potential volatility in future earnings, fluctuations in the Company's operating results, our ability to expand geographically into new markets and successfully integrate future acquisitions, PRC governmental decisions and regulation, and existing and future competition that the Company is facing. Additional risks that could affect our future operating results are more fully described in our U.S. Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended December 31, 2013, filed with the SEC and other subsequent filings. These filings are available at http://www.sec.gov. The Company may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the SEC. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

Contact:

Skystar Bio-Pharmaceutical Company
Scott Cramer
Director - Corporate Development & U.S. Representative
(407) 645-4433

GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X``02D9)1@`!`@$`2`!(``#_X0I@17AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````;````<@$R``(````4````C8=I``0````!````I````-````!(```` M`0```$@````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`Q,#HQ,CHQ M-2`Q-CHP-3HT,````````Z`!``,````!``$``*`"``0````!```"=*`#``0` M```!````9``````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```DJ```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`&0"@`P$B``(1`0,1`?_=``0` M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`Z+ZU=9ZO7UVOI73\HXCWTL?0X!I8Y[C9 MOKR#8RW9N;5^AN9_-?X;]';ZU&.>O]=9BVUOZR_[/LKLK^>;Z=++<#?L]&OU=GJ^A7ZJLQ`X8^GMT# MG99R]R?K(HRZR[?+_>=KZO\`6>ML^L5/2>HY?VJQ['.R!##6S]']HJ90^EE? MJ6^YOK6_S7^!K_TRUF_7&JZ_)KP>E]0SV8E[\:V^BNKT_5KTM8WULFFSV3_H MUSGU:%%'UEZ9A.PW8V;C46MR"ZQSB-[7WTU.J+=GZ*BQG_;FS_`J>8.E976; MZ#;]6WY=F2^H-OP7/N-F\L%=]WVAK;,G=['_`+]J9D`XMNG\I-GEI$P-FZE6 MNOZ,?2]CTSK%6?++*+<#)EQ;B9?IMN^VYGHLO_`$=_H_SJCX03HSWW>PRNM='P MRX9F=C8Q8\5O%MK&0\M%HK=ZCF^_TGLMV?Z-!_YS_5KT_5_:V%Z>[;O^T5;= MT;MN[U/I;5S='U-SWU-S:ZFUE@8#N(=:ZMSO3^@_Z:>[J_2L?$ MKS;\W'JQ+X%.0^UC:W[@7L].YSO3?O8W>W:LK+^K>9D?5C"^K]>:,=M-5-&7 MMC^C_`#'Z5GZ1*H]U6>STF%U+IW4&.LP,JG+8P[7N MHL;8`>=KG5.=M5E8W1/J_P#L?-S[J[SD4YSVV[[]UF2"T>FVBS-LL<_(Q:&? MT5EK?6J]_P"FM6R@:Z)4DDD@I22222E))))*4DDDDI__T.F^MG26W=39E5Y5 MF+?;1Z?JLHLNE_,6>DO04E/'CX15?\UI9/9XY63>MT)? MX7Z3Q?U8Z**^KTY-V5;DW8U3_3L?CVTN+2&U?9[[K_`-)] MG_1UQR?J#U"[(R',ZA755?F/S6N:,GU*R^[[6W94,]O3O5K^BVUV!_+^FNV2 M39':]?/\`PGA^F_XOY MOV3\STMO\RM.OZEX]V?U',ZID6Y?V\U^VJR[&$,J;BO;0S"'H>ZI^2<=]CGNMNO]6OU<>ZS_`W_K=O MHY-'Z'T^X22]:O2\=?\`XO:_'#B3E-:W%;NLL<[;T]_ MNIW?];])0L^H?5+&7>IU5EAR::\>ZM]-AK=7C^B[$KEX;+_Q?7Y5M=I9TJCTV65^CC8CJJSO-3O5>UM[MUK/1 MV?\`%O5W$^IN2P8N#FVXF1TC%RKLW[-]G<7/=_P!-6_\`F=U-V1@Y->9B8#NFN+\?&PL1U>/O>^G^D_P!&LY_U%R;+*+31T:O[,XG[/7@.%-NYCJOUNO[1^E=3 MNWXW[GZ1=JD@.+6J5IXO-M^K&:WZLN^K?VBHX]F);2;]C@YMMCR]GIU;W-^R ML98ZME>_U*_2K_ZW+J'U=S>M8IIZY]@OLJMILQ;:\9TL8RVN_,J/VF[(_I=5 M/H?H_3_X7U%T22&OUM.CQS/J&^CJ7VG$.%14S-&;38S&+$Z24KTM0KH__]G_[0\:4&AO=&]S:&]P(#,N,``X0DE- M!"4``````!``````````````````````.$))30/M```````0`$@````!``$` M2`````$``3A"24T$)@``````#@`````````````_@```.$))300-```````$ M````>#A"24T$&0``````!````!XX0DE-`_,```````D```````````$`.$)) M300*```````!```X0DE-)Q````````H``0`````````".$))30/U``````!( M`"]F9@`!`&QF9@`&```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H` M```&```````!`#4````!`"T````&```````!.$))30/X``````!P``#_____ M________________________`^@`````____________________________ M_P/H`````/____________________________\#Z`````#_____________ M________________`^@``#A"24T$`````````@`!.$))300"```````$```` M`#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0````` M.$))300:``````-)````!@``````````````9````G0````*`%4`;@!T`&D` M=`!L`&4`9``M`#$````!``````````````````````````$````````````` M`G0```!D``````````````````````$`````````````````````````$``` M``$```````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$` M```$`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO M;F<```!D`````%)G:'1L;VYG```"=`````9S;&EC97-6;$QS`````4]B:F,` M```!```````%7!E96YU;0````I%4VQI8V54>7!E`````$EM M9R`````&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N M9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG````9`````!29VAT M;&]N9P```G0````#=7)L5$585`````$```````!N=6QL5$585`````$````` M``!-'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R M=$%L:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB M9T-O;&]R5'EP965N=6T````115-L:6-E0D=#;VQO)E\K.$P]-UX_-&)Y2DA;25Q-3D M]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<' M!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C+RLX3#TW7C\T:4I(6TE<34Y/2EM<75 MY?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1`Q$`/P#HOK5UGJ]? M7:^E=/RCB/?2Q]#@&ECGN-F^O(-C+=FYM7Z&YG\U_AOT=OK48YZ_UUF+;6_K M+_MS,IM&P4!U8]M@=7ZS:-SG.L;^91_Y\WJY];W8[OK+9C.QCD9.3@BK&(L+ M(>XW>S:T>[UF;Z?^N+-;F],JZ5;@V4AG4VVMI&4;(%9AX^RNROYYOITLMP-^ MST:_5V>KZ%?JJS$#ACZ>W0.=EG+W)^LBC+K+M\O]YVOJ_P!9ZVSZQ4])ZCE_ M:K'L<[($,-;/T?VBIE#Z65^I;[F^M;_-?X&O_3+6;]<:KK\FO!Z7U#/9B7OQ MK;Z*ZO3]6O2UC?6R:;/9/^C7.?5H44?67IF$[#=C9N-1:W(+K'.(WM??34ZH MMV?HJ+&?]N;/\"IY@Z5E=9OH-OU;?EV9+Z@V_!<^XV;RP5WW?:&MLR=WL?\` MOVIF0#BVZ?RDV>6D3`V;J5:Z_HQ]+V/3.L59\LLHMP,F7%N)E^FVYS&;-V17 M53;?NQ]UK:_4_P!(CU=2Z==<<>G*ILO#GUFIEC7/WU;/M%>QKMV^CU:O69_@ MO4K7*].^H.;B6U.'4SC5SE'(KPF>C#,I]-WV3!=8ZYV%CUOQF>^O]/\`Z-]? M\XJN93]7^DX3>CW]3Q:NH](+F8%DWXCJJ;_2NL9F_LJ_&==?=5[[;F>BR_\` M1W^C_.J/A!.C/?=[#*ZUT?#+AF9V-C%CQ6\6VL9#RT6BMWJ.;[_2>RW9_HT' M_G/]6O3]7]K87I[MN_[15MW1NV[O4^EM7-T?4W/?4W-IRL;(OON=E,R?5S"6 M,?31C-^RY].=]NM9?73OM];*LJ_FO2_FUJ]-^K_5:.G=4QSK8G6>D9S+7X6=CY+,K$O@4Y#[6-K?N!>ST[G.]-^]C=[=JRL MOZMYF1]6,+ZOUYHQVTU4T9=S6%QLKI8&/J8W>S8S(L8SU=W_`&G]6I4J/J/D M,HIPK<\.PZBQM@!YVN=4YVU65C=$^K_`.Q\W/NKO.13G/;; MOOW69(+1Z;:+,VRQS\C%H9_166M]:KW_`*:U;*!KHE2222"E))))*4DDDDI2 M2222G__0Z;ZV=);=U-F57E68M]M'I^JRBRYS6,+MS<=V,YKZGV^M^F]OJ>E] M#TZ[+O4S?V'GLQC@GJ5F]U@N%QQ';P&;L:QK/A%5_S6ED]GCE9-ZW0E_A?I/%_5CHHKZO3DW95N3=C5/].Q^/;2XM(;5] MGOMR2[U/1;:Q]+/YZO\`TGV?]'7')^H/4+LC('Z;_B]RL&S%+O[&4<+R;?J1?C-K=T_/.,^C+R,K&JA[JGY)Q MWV.>ZVZ_U:_5Q[K/\#?^MV^CDT?H?3[A)+UJ]+QU_P#B]IRLA^5EOQK[[K,V MRU[\<.).4UK<5NZRQSMO3W^ZG=_UOTE"SZA]4L9=ZG566')IKQ[JWTV&MU>/ MZ+L2MS79CO:Q^.[U?;^F^W]0_P!,STNT22]?\J5Z7ALO_%]?E6UVEG2J/399 M7Z.-B.JK.\U.]5[6WNW6L]'9_P`6]7<3ZFY+!BX.;;B9'2,7*NS?LWV=Q<]U MSK=;C^C4[-?L_0?X&I=8DD>.M=E"K>'/\`BV971T\8[\/U<+UCD-LQ M9JR398RVIN74RUCK&8];-K/4?9[_`$U;_P"9W4W9&#DUYF)@.Z:XOQ\;"Q'5 MX^][YR+75MRF.<[)Q6_9+-W^#LO]/])8NM22/'U\?[5#A>;POJ]UNKH=G0,C M,QOL/V%^%3;338VYI+/0JOLWY+ZW[6;GV,9Z?Z3_`$:SG_47)LLHM-'1J_LS MB?L]>`X4V[F.J_6Z_M'Z5U.[?C?N?I%VJ2`XM:I6GB\VWZL9K?JR[ZM_:*CC MV8EM)OV.#FVV/+V>G5OFMC.60G/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STG6$U0('1O;VQK:70@,RXP+3(X+"!F&UL;G,Z6YT87@M;G,C)R!X;6QN&UL;G,Z97AI9CTG:'1T<#HO+VYS+F%D;V)E+F-O;2]E>&EF M+S$N,"\G/@H@(#QE>&EF.D-O;&]R4W!A8V4^,3PO97AI9CI#;VQO&EF.E!I>&5L6$1I;65N&EF.E!I>&5L641I;65N&UL;G,Z<&AO=&]S:&]P/2=H='1P.B\O M;G,N861O8F4N8V]M+W!H;W1O3X*(#PO&%P.DUE=&%D871A1&%T93X*("`\>&%P.D-R M96%T;W)4;V]L/D%D;V)E(%!H;W1O&UL;G,Z>&%P34T])VAT='`Z+R]N&%P+S$N,"]M;2\G/@H@(#QX87!-33I$;V-U;65N=$E$/F%D;V)E.F1O M8VED.G!H;W1O&UL;G,Z9&,])VAT='`Z M+R]P=7)L+F]R9R]D8R]E;&5M96YT&UP;65T83X*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0])W0``9&5S M8P`````````2D!\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0" M70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-# M`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$ M8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%#044%]@8&!A8&)P8W!D@&609J!GL&C`:=!J\&P`;1!N,&]0<'!QD' M*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2 M".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)^PH1"B<*/0I4"FH*@0J8"JX* MQ0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9 M#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/ M00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA') M$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4 MK13.%/`5$A4T%585>!6;%;T5X!8#%B86219L%H\6LA;6%OH7'1=!%V47B1>N M%](7]Q@;&$`891B*&*\8U1CZ&2`911EK&9$9MQG=&@0:*AI1&G<:GAK%&NP; M%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<]1T>'4<=:AZ4 M'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8(,0@\"$<(4@A=2&A(B>K)]PH#2@_*'$HHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K M`BLV*VDKG2O1+`4L.2QN+*(LURT,+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1 M+\<-]1B)&9T:K1O!'-4=[1\!(!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+ M4TN:2^),*DQR3+I-`DU*39--W$XE3FY.MT\`3TE/DT_=4"=0<5"[40914%&; M4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755PE8/5EQ6J5;W5T17DE?@6"]8 M?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R&7-9=)UUX7&EYL7KU?#U]A M7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)F MZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK M;L1O'F]X;]%P*W"&<.!Q.G&5&YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G[" M?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7@[J$'82`A..%1X6KA@Z&I+CDTV3MI0@E(J4])5?EAMJ(FHI:C!J-V MH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H_R#W(O,DZR;G*.,JWRS;+MLPUS+7--$S%F+P)'*"\25#-%.2HK)C<\(U1">3 MH[,V%U1D=,/2X@@F@PD*&!F$E$5&I+16TU4H&O+C\\34Y/1E=865I;7%U>7U M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_(B8J+C(V.CX*3E)66EYB9FI MNGM\?7Y_(B8J+C(V.CX.4E9:7F)F:FY MR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H`#`,!``(1`Q$`/P#U3BJA>WUG8VSW5Y,E MO;1BLDLA"J.VY.$`G8,9S$19-!)/^5B>1_\`J]6NPK]OMEG@S[G'_.X?YT6O M^5C^1?\`J]VO_!X^#/N7\[A_G1=_RL?R+_U>[7_@\?!GW+^=P_SHJEMY^\F7 M-Q';V^L6TD\S!(HU?=F.P`P'#,=$QUF(FA(-3_F!Y*@F>";6+9)8F*2(7W## M8@XC#,]%.LQ`T9!9_P`K'\B_]7NU_P"#P^#/N1^=P_SHN_Y6/Y%_ZO=K_P`' MCX,^Y?SN'^=%O_E8OD:@/Z;M=S0?'WQ\&?VT=U:3)/;R MBLT=;P9?#D.+&1ZGD?FORF=&>&[LY1?:%?5;3M144#`=4< M?L2I^TN9N/)Q;'ZG2:G3F&X/%"7TR_'\3'Z#PRUQ;=0>&*VR#\O[2>Y\[:+' M!&9'%W$Y"CHJL&8_0!E68U`N5HHDY8U_.:\^V4]GYSUF"=>,@NI&Z4J&-01\ MQCA-P"ZR)CED#WI!0>&6N+;J#PQ6V1>4?*B:N\]]J$OU+0+`<]0OF&WM%'_- M*_[*Y5ER<.P^HN7I=/QW*1X<NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]'U3BKYD_YR#/\`SO["G2UAW^_- MMHOH>3[:_OO\T,6\J>:H],6;3-4A-]Y=OJ"]LS]I2.DL)/V)4Z[9=DQWN/J# MAZ;4*);2[AH'"-N!(A/PL.A_R MLKCJ8\I>DM^7LS)SA^\A+Z4)'^6FI6:B?S-=P:!:TY4NN/^*X5^)LEXX/ MT^I@-!*.^0C&/]E_I6?_`)6>8/RHT36HK'3_`*S/JET1!'JMS&%#%Z?"JC^[ M!.V8VHADD+/)V?9^;38YU&^*7\+LR?U9/W<(_4DOFOS7^E1#IVG1&R\OV/PV-D#N:;>K* M?VY7[G+,>.MS]1:-3J>/TQ]../TQ97_SCU_RGQ_YA9?X93K?H3WCRWK<6N M:#8:Q%&88[Z%9EB8U*\A6A(S$E&C3E1-BTRR*78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%7_]+U3BKYD_YR#K_C\^'U6&GXYMM%]#R?;7]]_FAYIF6ZA]"_EUY] MT+RE^7FDIYANFCENVE>TA",[^CRH&H/V:US5YL1G,\+U&BU<,."/&?J^G^J\ MR_-JWN[GS+)YA2?Z]HVK4?3;U=T"`?W/^0\?3@Q_K!;YQ55\V:PJBBB[EH/]D<<7TA M&J_O)?UBR+\I+:[M/,>]%\V_EUJ8\NW)GDMGB:\MRI200\P"_$[\`>^8N M#$89!Q.VUVKAFP2X#=?4^>\V;R[TW_G'K_E/C_S"R_PS$UOT.V[&_OO@7TSF MI>M?"OYP222?F?YC:0EF^MD?%N:!0`,VV'Z`ZW+]1>E_EYY._(2^\G:==>8K M^&+694)O$>Y]-@]>G'ME&2>02VY-T(0(WYLC_P``_P#.,7_5RM_^DS(>)E[F M7!C;_P``_P#.,7_5RM_^DS'Q,O/$;Y&6;(.;(8L9Y(G\T/S3_`.53QZ'H>D:1'=VI*R%%A(4+L&K6N# M%B\2R2N3)P4`SG\MO-\_F[R=8Z]/;K:RW?/E`C%E'!BNQ('AE62'#*FW'+B% MLFDD2-&DD8(B@EF8T``ZDDY6S>+>;_\`G)_ROHWF"'3M,MFU>SC?CJ%[$U%7 MM2'_`'X1_P`#F5#2DBSLX\M0`=DS_-+\[Y/*&F:%J.G::+Z#6D>11<,T#HJA M2*KQ)J>61Q8.(D'HG+FX0*91^57GFX\[>3X->N+1;.6666(P(Q=?W;4K4@=< MKRPX94SQSXA;+\K;'E7YS?G1>_E[?Z;:VVF1WXOXI)6>20Q\?38+0``UK7,C M#A$^K1FRF*M+^>.F:?\`ECI_G+5[4QW6H\DM=-A;D7E5B*!B-EVY,<'@$SX0 MGQ@(V7FQ_P"8?^I9BZ_[^DZ? M\!C^4'>OYD]SO^AM/,/_`%+,7_(Z3_FC'\H.]?S)[F9:I^?.KV7Y::5YO&AJ M]SJ-R]NUF7<*BI6C_[Z3_FC+?R M@[VO\R>Y8/\`G+G7"0O^'("W<>N]?^(X?R@[U_,GN7_]#:>8?^I9B_Y'2=/^ M`P?E!WK^9/<]H_*OSS=^=O*<>N75C^CY7FDB]`,6!$=/B!('6N8N6'":[M8KJVD$MO.BR12*:AE85!!&81 M#E@I#^8GFY_*/D[4/,*6PNVLE5EMRW`,6=4^U0_S9/'#BE3#)+A%O#5_YRYU M1OL^6HVIUI.Q_P"-,R_R@[W&_,GN7?\`0VNK_P#4KI_R.?\`YHQ_*#O7\R>Y M'Z)_SEG;2ZA'!K>A-9VLC!6N(9?49`QIR*,J[#YY&6DVV*1J>\/H&">*X@CG MA8/%*H>-QN"K"H(S#(/(:^F/IC_FK_`"IYKCTV.;2M6A-]Y69/Q(W::$_L2I_PV.3'>X^ MI.FU(CZ9#BQR^J/^^C_299Y:_*W6U\WZ1J&CE=1\O-.ES!JBD!?21@Q$B]4D M7[)7^;*,FH'"0=I.;@[/GXL91]6.^+C6:_\`E?K`\VZM?:X/T7Y2YNSY>+*4_1CN^+_B6*^:_-:ZHL.F:9#]1\O6/ MPV5D#NQ[RS']N5^IR_'CK<_47"U.IX_3'TXX_3'_`(K^DUY#U>'3?,EO]:'* MPO0;._0]##/\#'_8UY8YHW'S1HLHAD%_3+TR_JR07F?0;K0=>O-*N49&MY&$ M9;]J.OP./9EWR6.8E&VO483CF8GHSG_G'K_E/C_S"R_PS'UOT.P[&_OO@7TS MFI>M>/\`YM?\X^6/G+4CK>DW:Z;J\BA;D.I:&;B-F8+\2OVJ,R<.HX11Y./E MP<1L/+S_`,XG>>:G_3LVJ^6=>F%I<-;:GID[QBX@)6DD3$$CQ7;,C:0 M:=P7J?\`SD/J]QK&G>1M4N0!<7>F22RTZ;=G-@/6_RA\T: M%Y9_)/2]4UJZ2UM(Q,>3'XF/JM\*+U9CX#,;-`RR$!OQ2`A9>+_F=^>?F+SS M=?HC22VF:%*XB2#D$DG+&@,S_LK_`)&96+`(;GFX^3,9;!ZU^4?_`#CSHOE^ M.WUKS`8]4U<@201"C6T%14%>TC_Y?_`YCYM03L.3?BP`;E!_\Y3>4=O?\X_^4KS2K=[HZ2\\ES`@+2>G(Q!91WX\L\QGN(Y!)5Z?#LO04RS)A$C=L(9>$53)_P#H9W6O^I/L?^`D M_P":@^:?+=EJVG1J^G72!XXG0#@1U4KT#*F1\-/5.U/#-I+^[^#KXCU_%]L?HS3?^62' M_D6G],U=EV%!7BBBB0)$BQH.BJ`!]PP)>!?\Y/\`YEFRL5\F:;+2XO%$FJNI MW6#JL6W>3JW^3F9I<5^HN+J,E;!Y8&_*YO.GQ"X!]8:;QW^ICK+X\OV MN/\`)E_CCCX6GP3PV]._YQA_,T75FWDO4Y:W%LIDTEV.[0]6BW[Q_L_Y.4:K M%_$&[3Y.A9]_SD'_`.2CU[_4B_Y/)E.G^L-N?Z"^8/RP_,35/)EQ?2V&C0ZN MUVBJZS([\`IJ".`.9^7&)V_F#W,&UZ^\S?FKYO2[TS152[=(X&M[,$Q(%/VW8_9Z_$QRV(&..Y:I$ MS/)]IZ#82:?HEA8RD-):V\4+D="R(%-/NS5R-EV(%!'8$NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*O_]3U3BKP3\YH?(C>=6;7)]0CN_JT?PVJ(T?$5INQZYL= M*9\&U/.]IC#XOK,KK^%F'Y.VGY:+97#^6':>]``O)+L#ZR%(Z4I0)_JY3J3D MOU.;V;'3T?#W/]+ZWEOF^U_)U?,-V(+K45_>MZRVR(T( MCJ-3'2\9HS_S4E%O^4]!6[U?H:_NXOZY9>7^BT<.F[Y_[%]&_EC'Y<3R98CR M\[OIU&(:7^\,E?CY#QKFKS\7$>+F]/H1C&(<'TK?S17RVWDV\'F)Y(].JE6A MWD]2OP<1\\=/Q<8X>:Z_P_"/B?2^=?J_Y3[_`.EZMU-#Z<70?3WS:7E_HO,< M.E[Y_P"Q3KR=;_DX?,5G]8N=0;]XIA%TB+#SK\*R%*GKE>4Y>'HWZ:.EXQ9E M_G?2]0_.2U_+1K.*3S.S0Z@PI:O:`&Z(':AV*?Z^8FF.2_3R=OVG'3U^\^K^ MC];$OR8B\B)YRKH=Q?RWAMY/AND18PNU=U-:Y=JC/AWIPNS!A\7T&5U_$]YS M7/1/GOSK_P`Y-:SY?\V:IHL.BP30V$QA25Y&#,`!N:?/,R&E!B#;BSU!!JDE M_P"AN->_ZL-M_P`C7R?Y0=['\T>YW_0W&O?]6&V_Y&OC^4'>OYD]SO\`H;C7 M_P#JPVW_`"-?'\H.]?S)[GB5]->Z_KUS-!;F2^U2X>1+6(%B9)F)XJ/FI_\Y!:5=:3I?D33;L`7-KI;QS*.S!DJ/HS'TYLR/FWYQ5,=\@?EQYX_ M,,VUI#+)%Y?L25%W/R]"(,:L(EZ.Y_RN^;_P#G%?1G\OPC MRQ/PYCPU1O?DWRTPK9@?D+\X/.?Y9ZH?+GFFV MGGTR%@DEG-7UX!6G*%C]M/\`(^S_`"Y;DPQF+#7#*8&B^L-,U"VU+3K>_MN7 MU>ZC66,2*4;BPJ.2G<'->11IS0;8G^8WG;R?Y&L;6_UJP,R7DIAC]"%';D%Y M&M:=LLQPE+8,,DQ'FP+_`*&6_*;_`*M-S_TBQ?\`-67?EI][5^8CW/(/SP_, M3RMYTU+3+G0+1[6*TADCG]6-(BS,P*[*36@&9&#&8@VT9IB7)[-Y2_,/2?RW M_*3RL_F.WN5?4%D$$,2!GH"7JP)6@*LIS&GC,YFG(C,0B+4G_P"K-;1$_3\6/Y:?>C\Q%;_P!#+?E-3_CDW/R^JQ?\U8?RT^]?S$>YY3^> M/YE^4O.C:4=`M)+460E^L-)$D7+GQI3B36G'+\&(QNVG-D$N3Z`_YQZLKJT_ M*O2DN8FB>0RRHKBA*.]5-#XC,34'UERL'TAZ1E#:^(/*9!_.RP(W'Z;_`.9Q MS:R_N_@ZZ/U_%]OYJG8L=_,#SG8^3O*M[KMWOZ"\8(OYYFVC3Z6R>.'$:83G MPBWQ9:Z1YX\^ZW?ZG8V4^K:A))]8NWC`(4L:J*L0*?RKFT)C`5R=?1D;>F"\ M_P"1=8L=4O[*;2;Y) M?7LW>@#,AJP!4D4\1EX,9BN;21*)M]&_F!YUL?.7_..^I:[:_`9HHEN8O]]S M+,@=?E7[/^3F%CAPY:ZM_QJ?AS%QY#$[.3/&)#=\R:OY<_,?\D_,0 MU.PE,VFRMQ6\52UO,E:B.=?V&_S5LSA*.44X9C+&;?1/Y4_FOI7G_2Y)8(7M M=2M`HOK5@2BENA22G%E/_!9A9<1@7*QY!(,ZRIM=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5?_5]4XJ^9/^<@Q_SO[&O6UAV^_-MHOH>2[:_OO\T,,\H^8[GR[Y M@M-4A8A8G`N$'1X6V=3_`+'+\L.*-.#IM%32?,UU#"Q>SN*7=E( M?VH;CXT/T5XX,,KBRUF+@R$#D?5'^K)ORGY4?6'EO;V3ZEH%D.>H:@^P"_[[ MC_GE?HJC'+DX=A]2=-IN/U2]../U29IY8_-/4XO->CZ1H$:V/EF.9+6*P(#, M\6)9GMI;)0%DB16HLD3=?43[6"&G`B#'ZES]HDY)0GZL?T\+"?-?E231) M8;FVF%]HE\.>G:BGV77^1_Y)4_;3,G'DXMC]3KM3IO#W'JA+Z9?C^)OR+H\> MJ>9+9+@\+&TK=W\AZ+!!\;_?2F#-*H^:='BX\@OZ8^J7]6*'\V^8[SS%Y@O- M5NG+&9SZ*GHD0V1!\EPXH",:8:G._+75M1N-2U#0K>>]NFYSS-RJS4I4T.6C-("@6LXHGHA?\` ME17Y3_\`4N6W_#?UP^//O1X,>YW_`"HK\I_^I`&1)MD!2O@2E.K>4O+.KW]GJ&IZ;!=WE@W.TGE0 M,R-_'_99(3(%!B8@\TV``%!L!T&19)-YH\F^6?--K#:Z_81W\$#^I"DE:*Y% M*BA';)1F8\F,H"7-CG_*BORG_P"I7;42QFJ$J6`/R)(P'/,]4C%'N9JB(B M*B*%111544``[`#*FQO%6(6OY2?ES:ZRNLP:';QZFDWUA+D\@CN8'^U%*H=3]!KA!I!%H'0/*OEWR]%/#H MEA#81W,AEG6%>(9SW.&4R>:(Q`Y)KD625>8/*GEWS%#!#K=A#?Q6T@F@69:\ M7'<9*,R.3&40>:O^@M%&FMI8L8!IS#BUH(U$1'NM*8.(W:>$52W2?+VA:.)! MI=A!9>K0R^B@3E3I6F$R)YJ(@:9ENI>_P#D#\OM"\Z?E]H\^N0N+BS,D-O<1MQ=H`Q*JQ[J"6I_+FLS M9C"9IZ;2:.&?#$S&\?\`P?7]"U9B+ MFT-?W3*I(GC(WC=:;L,JU`H<0VD'+[.D92\(CBQS_'$]$_,#\O\`1O)?Y?:K M+H,4GKWC1175Q(Q9Q`7^)`=J)_-F-AS'),<3M-9HX8,$C#G+_M?+/YI?GC^9NA_F'K>C:5J$, M-A9RHEM$;='8!D!I4BK$DYGXL$3$$N'DS2!I(_\`E=G_`#D!_P`7_P#<-_YL MR7@8V/BS62_GY^>5B4FO)O10MQ7ZU8B*-V'[-2H_##^7QE?&D'T?^5GYD6OG M3R5!K]PB6,Z,UO?HS`1K-'LW%C^RW[.867'PRIRX3XA;,?KEIZ'UCUX_0_W[ MR'#_`(*M,KIG:C^F-(_Y;K?_`)&I_7&BBPJP7UE<,5M[B.9AN1&ZL1]Q.-)M M6P*\I_YR'\^^9_)OEG3KSR_/';W-U>""221!(>'&NP;;+]/`2.[5FD0-GA]M M^>_YZ7<9EL[EKJ,&AD@L%D4'K2JJ=\RS@QAQ?&FJ?\KL_P"<@/\`B_M_TK?' M_88/`QI\6:9^4?\`G)+\P].\R6UMYK5+S3Y94@NX3`+>XA]0A0Z@`="=U;!/ M31(V90SFZ+ZG@U&PN'X0W$Z@US`IR[1&!*C%>V(!J,-(M4EFBAC:29UCC7=GXCA8[@2.JG\3AI;4OTQI'_+=;_\`(U/ZXT46'?IC M2/\`ENM_^1J?UQHK81$,\,R>I#(LB'HR$,/O&!+P`@T(,J5!'TXT5L._3&D M?\MUO_R-3^N-%;#:ZKIC([K>0%(Z>HPD0A:]*FNV-%;"O#<03QB2"198SL'1 M@R[>XP):GN;>W3U+B5(8ZTYR,%%3[G&E46U73%5&:\@59!RC)D0!ATJ-]\-% M%M?IC2/^6ZW_`.1J?UQHK8;35=,D=4CO('=C1561"2?8`XT5L*D%]97#,L%Q M%,R?;6-U8CMO0XTMJ;:MI2L5:]@##8@RH"#]^-%;#7Z9TC_ENM_^1J?UQHK8 M1,[M4G6W>:-9W%4B+`.1[+6IQI;5:TW/3QQ5 M1M[ZRN&9;>XBF9?M+&ZL1\Z$X:6U;`KL56R2QQ(7D<(@ZLQ``^DXJAOTQI'_ M`"W6_P#R-3^N&BBPY=7TIB%6]@))H`)4J2?IQHK:K/?65N0+BXCA)Z"1U6OW MG&DVI?IC2/\`ENM_^1J?UQHHL(F*:*9!)$ZR(>CH0P/TC`E=BKL54(K^QEF, M,5S%),M>4:NK,*=:@&N&D6KX$K99HH8VDF=8XUW9W(51\R<50WZ8TC_ENM_^ M1J?UPT46'?IC2/\`ENM_^1J?UQHK8;;5=+4*6O(%#CDA,B#D/$;[C&BMAK], M:1_RW6__`"-3^N-%;"K!>V=P2+>>.8CJ(W5J?<3C2;5L"NQ5V*NQ5V*O_]?U M3BKYD_YR#)_Q^1386L-#]^;;1?0\GVU_??YH8EY5\JR:S)+=74OU+0K&CZEJ M+_91?Y$_GE?]E!EV3)P[#ZG"TVF\3<^G''ZI,GU7\Z-?BCCTSRQQTC1;-1%: M(JAI61?VG8[J3EY>U)CTX_1"/TI;)^9$NJ\4\UZ;;ZVH`"W)' MH7*CVE0;_P"R7)>!7TGA:OS_`!_WL1D_V,V>_E=Y._*_6M9AU32[NZ^MV++- M^B;DJ&5QN&Y#^\13X9CZC)DB*/7^)V79^FT^27%$FX_P24_S0\G_`)7Z%K,N MI:C=W1O+US/^A[8J2Q8[GD?[M"?''!ER2%#_`$R-?IM/CEQ2)N7\$6#+^9$V ME!?U'B==^?,-L0&/_93_P!,F6D_G+KD M\4VE^:J:MHE\IBNE("S(K;Z+>@OINI(/@D3^5OY)4_;3+<>3B_K.'J=,<9L>J$OHFR__G'K_E/C M_P`PLO\`#*=;]#F]C?WWP+Z9S4O6OA_\['*?F_YC=/MIF1\#&S\2;'_`#IY_P#S+\VV$%OY MFAF>RLI/71A9O`JM3C5WI2F^3ACC$[,)RD1NC--\RVLOY%Z]Y6"O%?6>H07W MJAB%EBFD`IMW0]L!C^\!2)>A+-:U;5IO*7DSR]]GZ5K,]Q,SVTCSMR562:3@\;)R964C+1(9($TP-PE5OL[-:YKPG_G M+C_E#M%_[:2[?[`YE:3ZFC48RR<;1K@>JP`; MXQTZ#;,O)CC(V7&QSD!LG_\`RO?\]_"7K_U;7_ID/!QL_$FE?E_RS^87YB_F M!!?W=A.MQ76F0R0,H"F<)@2W>[/\`\Y)?E"T;*-98 M%@0/W$O/%Y#_`,XQ3&?\V=8G$KR+/:W$JL[,W)7N`5)J3^S3 M,C4BH!IPRN3(_P#G*'SW-=7-C^7VD,[W%P\>?0+/^<8//=S97]]^7NL,R30O)-IJRDEU=#2>W)/\OVU_V6'4X_X@ MN"?0I!_SE`EO-^:.D07ER]M9-9H)YU+'THS)\3A`14@=LGIOH8YSZF)S^4OR M56&5K?\`,.]FG16:*(V4P#N`2JD\MN1R8E/^:P/#WO6O^<3-8U>X\N>8+2XG MDGL;"Y7ZEZI9PA="757:NVP^']G,?5Q%ANP$D/+/)_E35/S9_,+6;35];N(+ MA/6G^LU:39)2B1JG)550,OG,8XC9JC$RES;_`#B_)Q/RYLM.N1J\VIM?O)&4 M<-&$X+RJ*.:X<.7CZ(R0,>K,_+G_`#BQ'K7E_3M7_P`37$`O[:.X:$1D\/44 M-Q!+BM,JEJJ-4SCA)%VI?\XPZEJMA^8FM>6EO)9M+2*;E#(S,#+;R^F)%Y$\ M.0ZX=5$<(*,$CQ4G7_.4/GV6>:R_+_279[FY>.;4A$3R/(_N+<4WY2-\3?Y. M0TV/^(L\\^@4/^<8?/5SI^I7_P"7NLN\B]+_`.<3ET[5+34? M\4W#?4Y5GX",@MZ9Y<:\]JX#JK')(PD=7A>EZ=Y8U/S/JB>9-;FT&P6:=H[Q M$DG+2"0@1\`P[=\RB2`*%M%[[FF0_P"#_P`E/_+D7?\`T@S?\U9#BG_-30[U MVI:)Y$TWR-YBD\K^:[C7KB0V:W-O)#);^G'ZAHX+-\>^(,C(6*2:K8OH'_G& M3_R4FG&I),]Q4L23_>'QS$U/UN3A^E*O^C,O\`I\/V6*^/AATO MU,4LFMVM@ID6JS/\2GDM*]\MEGX)$4PCC,HW M;SKSK^6L?EK\R+/R6-2ENENVME-^W)67ZR:?8#$?#E\)\4>*FJ0(E5O8-/\` M^<64T._BUH>9KB8:?SN!"(RI?BC?#7GM7,8ZFQ5-PPD=7BOE?7-6TSRYYRN- M.NI;6>[$5O+(CGD(I9SS523\)(VY#,DQ!(:>(@%G?Y8+B MRDO&D#6_%I*>FY2O(N"2:95DU'":IG#$9"[9*?\`G#Y:4_Q5/_R*/_53(?FQ MW,O`/>]D\IZ):?E]Y!@T^^U!KJUT:!WGOIOA)1:L=B32G0;YC2/'+9O`X1N^ M/?-?G/S1YG\VW_GVT$\*6-S%]4F0L([5%;_1XWIM^]XU;_6S8P@(CA<.4R3; MZZ\I>=;3SC^6XUVV(62:TE6ZB!WCG1")$/A1LU\X<,J)S*U?(-&G))+ZES`GU!HI8XA;,A0'U#2O(.3MF=BS\1J MG%GB,1=KORR_YQYC\\>4+?S!^GI[`W$DD;6RH9`/3/&H8N.N#)J.$U2PQ&0N MTB_-[R4OE;S+Y<\J?7I;P0V4<37CEE/[^X8?9#'9.6V3PRX@2QR@Q-/1E_YQ M!1E5E\UW%"`1^Z/S_P!^93^;\FSP#WL`O?+^J?E;^<6D:1I.KSW$GJ6S23MR M421W+<7C>/DRLM,M$A.!-,2#&56^SLUKF.Q5V*NQ5V*O_]#U3BKP_P#-SR!J M&J>=!K5[*EGY9AMD-[J#-5D6.O)0G4NW2/-AI\P$*'U.@[1T9GEXY'AQUZI/ M*_-7FN/48H=)TJ(V7EVQ-+2TK\4C=YIB/MRO_P`+F9CQUN?J=-J=3Q`1CZ<< M?I_XJ7])CE1EKB.J,59%^7E]0QN;J-&([H[!64_,'*LX!@7*T4C M'-$C^^79;5C8ZBI`]59#\(*]5=?VQF%JWY@._?#WYU7,47YQ^892RDPW<$G`FE3&BM3\,VF$>@.O MRFI/1E_YR\9$51Y9C(4`5^LIVV\,I_*>;;^9\DI\W_\`.3I\Q^6-2T)M`CM1 MJ,)@-P+A6X5_:I3?IDH:6C=HEJ+%4\ZT73;P?E[YGU8H5TQ6LK5+EJA7F]0' MBE?M4'VCEQ/J`:@#PEVM*\&A>2=2E0BP,4@6X&Z,T-V7=`W3G3]G$8?Y63E>/%Y%Y]\ZZ;^8?YM:'J7EN&:0L MUO;Q02)^\,L;EJ\!7X%ZL- M=NWAF)>+SO5<47@/Y(>9=-\J^;_->M3FMMI6GW1B@7XF8I<< M8XQ3Z!F9GCQ1`<;%Z9%(_*UQ^9&J>9Y//VDZ'+KNHFYDF-QZ7JV\<[C8#_*B M7[/\N3EPB/"32!Q$VUYME_,BQ\R)Y\UG0Y="U`7$4PNA%Z,#7">/^5*HXO\` MS8PX2.$&T2XKME'YI:_I7G'\PO(FJ,O*QUJUMUN;9P5/Q3<98S].5XAPQ(;, MGJ(+T;\T_P#G&K1+O1OKGD>V2PU:T!8V(8B*Z3J5WKPE_D;*<6I(/J;,F`$; M(/\`YQY_-&Q2W/Y=:MIPTO7;,2B'TXN`FX`EQ,H'PSK^TS?#)AU&/^(I^@,>7R#4?H^"A'3^['AF-D^HMT/I#YA_)WS+I_ES\Q/. M6O73N8_6@29OL@>+1+LO\`+DY<(CPDT@<1-T[SA+^95GYB3SYK6B2Z'J`N M(I5NQ%Z,#3H-J_Y4BCBW\V,!&N$&T2XKND__`#S\Q1^8M3\G><5B>/3K^QC9 MG8%0)H90TT6_[2TV_FR&"-`Q9Y39!>KI_P`Y:_EJB*GH7QXJ!7TAV'SS'_*2 M;AG"(L?^L3R(!&W',R0D8CA<6)CQ;LW_`,7?\XK_`/4MWGW/ M_P`UY5P9>]MXL?:/<6=_:_59]19U9B;42$,15F^%3] MK#$3$AQ%$J(V"??E!_SD%Y(\E^1;/0=32ZEO())7=X4#I21RRT:OAD MX?D):7=K^4OEZ*ZA>"7T&?TY!Q;B\C,I(/\`,IKF+G/K+?B'I>&_G1)&/^H97 MA0/&?44`4R\_\`.7'Y:@$_5[X^WI#^N5_E),_'#%?S MZ_.2T\Q>3]#T?R_ZRP>94%S<\E*NT*OQ6``=7DD^TH_9R>##1)/1CFR;;,,T M>S_.+2O*-_Y4M_)4LFDZH2UZTMM69RU.)+UZQT_=_P`N72,#*[:@)`52/_([ MS7J7E'S3JGDG689K--9@D5K2=2'@NQ$>#,HK195VKD<\!(<03BD1L4H_(K\S M_+GD#6]8O=:$LD=[$L,(MP'8-'(Q/+<>.2SXS,"F.&?"=WLW_0V_Y:_[XOO^ M10_KF-^4DY'CQ9I^6OYP^5OS"DOXM%6=)-/"&=9TX[25XD;GPRK)A,.;9"8D M\4_YRTAFB\X^7KV5&6S^KE5G(^`NDH=DKTY<>V96D^DN/J.89G;_`/.67Y:P MP11>A?'TT5:^D.PIXY4=+)L&>*)L_P#G*W\N+R]M[.."^$EU*D"$Q"@:1N*U MW\3@.ED$C,"\7_+SSII7Y=_FMK>H^8(IXU5KFW,")64-))S4E33X2.^9.2!G M`4T0EPRW>P2_\Y:?EK)$\?H7PYJ5_NAW%/',?\I)N\>+"/\`G$^&:?SYY@OH MHV:S-LU9Z?`&DGYJA;ISX]LNU1](#5@'JM[M%^:OEJ3S'YBT&DR7/EFV^MZA M*R4CX<>1X'N:9A^$:![W)XPG/D_S38^:O+=EK]C'+%9WZ&2%)UXOQ!*U(]Z9 M&<>$TRB;?(?Y?^>]#\D_FYK.O:MZCVBRWL`6`!WYO)MM7IFQR0,H`!PHR$9[ MO9_^AM_RU_WQ??\`(H?US&_*2;_'BRG\N_SU\G>?-9GTC2$N8[N&'ZP1/'Q4 MH#0T()WRO)@,!99PR"24_P#.43*OY3718@#ZW;[G_6.2TWUL<_TJG_.,1!_* M2P(-1]8N.G^OCJ?K7!]+R/\`YR?N8;?\VM*FE:B0V=O*XJ*\4G+&E?89DZ7Z M"T:CZGH:?\Y:_EHB*@@OCQ`%?2'8?/*/RDF[QXO(?-OF_3_S!_.K1M5\OPSR MQS2V<2P%*2UA>KMQ%?@`_:S(C`P@06F4N*6SZEM/S%T*Z\_W?DB-9OTM9VHN MY7*4BX$@4#>/Q9@G&>'B,2)]/-HU$L8@3D^AY[8VOY,WLT%O#Y;N/W]$C=K M2Y"4ZM)IL"6ECFW-PD%TDL+- M"=RPY-V_X7!*>4"[3CPZ61X>&C7\5_2@K?4?R.M9H+RSTX&X]>EDT,,SO(\' M5H@">2K_`#9(C,=B6L3TD38&]^G:7\/\U4F;\H;F2>^G\N7+R-)ZLSM9W(9G M?:M.^`>*-K^U).FE2U;XEKD9RR MQ%DMN'%I,A(C$7%*3+^1G.XCCT&29;5GAGDBMKAT4J?BJRDY/]]WM-Z/>HGK7$D8+M04%3DQDD-@6)@"AO\`E4WY:_\`4N6/ M_(H8?&GWH\./<[_E4WY:_P#4N6/_`"*&/C3[U\./C+HEQI=L^D M(05L?341`J:@A0`*Y$3-W>Z>$52E)Y)\HR:-%HDFD6K:3">4-D8E,:,34E13 M8[]$527?\JF_+7_J7+'_D4,/C3[T>''N1VC^0_)FBW?US2M&M+.[` M*B>*)0X!ZT;J/HP2R2/,I$`.2?9!DE^N>7M#UVT%GK%C#?VRL)%BG4,H8="* MX8R(Y((!YNT/R]H>A6C6>C6,-A;,YD:*!0JECU)IAE(GFH`'),,BEV*I+I_D MORGIVKRZQ8Z5;6VIS6 M6C6D%S>*RW4B1+^\5CR8,*4-6WR9G(]6/"$RTK2-+TFS6RTRUBL[169E@A4( M@9C5C0>)R))/-(%.U72-+U:S:RU.UBO;1RK-!,H="5-5-#X'$$CDI%H:X\K> M6KF>UGGTNUDFL0!9NT*$Q`&H$>WP?['#QGO1PA-,BR2Z'RWH,.LSZU%80)JU MR@BGO0@$KHO0%L/$:I%!0TCR=Y6T:]N+[2M*MK*\NJ_6)X8U5WJ:FI'OA,R> M:B("_7_*OESS#%%%K>G0:A'`Q>%9T#A6(H2*XQF1R4Q!YIA;6MO:VT=M;1K# M;PJ$BB045544``';(DI2G3_(_E#3KVYOK+1[6WNKP,MU*D2@R*YJP;Q#'KDS M.1ZL>$(_2=&TK1[-;+2[2*RM%9G6"%0B!G-6-!XG(DD\T@4WJND:7JUFUEJ= MK%>6CD,\$RAT)4U!H?`X@DQ\./LHY MX6#Q2"):JR[@C$Y9=Z^''N:F_*S\NIYI)Y?+UB\LK%Y',2U+,:DXC++O7PX] MRS_E4WY:_P#4N6/_`"*&/C3[U\./CVMH;I/2N?3C4>I'_ M`"MXK[8#DD>92(`(!ORH_+9F+'RY85)J?W*CKA\:7>CPX]S<7Y5_ES%*DL?E MRQ#H0RGT5-".G7'QI=Z^''N94JJJA5`"@4`&P`&5LTEU#R7Y4U'5X=8OM*MK MC5("IAO)(P9%*&JT;_)[9(3(%6QX0G+*KJ58!E8493N"#V.19)-I7DGRCI(N MQIND6MJ+\%;P1Q*!*IZJXINN_P!G)F9/,L1$!+?^53_EM4_\ZW8?\B5P^-+O M1X<>YQ_*;\M2*'RW8T/_`!4,?&GWKX<>Y-E\H^5UAL(1I5KZ6ED'3E,2'T"- MQZ=1\.1XSWLN$)MD4H`Z!H9U1]5-A`=2E01/>&-3*4`H%YD5IAXC5(X1S2-O MRH_+9F9CYYK_E4WY:_]2Y8_P#(H8^-/O7PX]R; MZ#Y3\M>7Q,-%TVWT\7!!F]!`G(KL*T\,C*9/-(B!R5]9T'1M;M/J>KV4-];5 M#"*=`ZAAW%>AP1D1R20#S2'_`)5-^6O_`%+EC_R*&3\:?>Q\./0_)FM7GUS5=&M+R[XA3/+$K. M5'0$]Z8(Y)#D4F`/1`_\JF_+7_J7+'_D4,/C3[T>''N3W1M!T71+,6>D64-C M:U+>C`@12QZDTZG(2D3S9``92(@V4A!>"90R$KN#0X!(CDDBW:/HNE:-8)I^E6L=E915,=O"O%`3N=L3( MGFH%('7/)'E'7KI+K6=)MK^YB3TXYIHPS!*UXU\*Y*,Y#D4&`/-+O^53?EK_ M`-2Y8_\`(H8?&GWH\./ULKIEX&>&)5?CX!NHP2R2/,I M$`$U73[!+Q[U+:);R10DER$42LHZ*7IR(]LC932O@2[%78J[%7__TO5.*I%Y MWTF+5?+=U9R:8-6#\2MEZ@A+$,-Q(?LLOVLLQ2J5WPN/JL?'C(KC_H_2\VMO M*?Y@)J6G?H>UO='B@E!N)+K45N8O0'^ZQ$/;;,HY(4;J7P=7'39A(<`EC_K3 MX_3_`%4/9_E?YNM&FUN&WCEU6SU26YMM,N'#6\\#G[0'V4D_E8X3GB=NG"PC MH,L?6!ZHS,N"7TRBRK\S/*FJ^:?+VFSVEAZ.LQ3QF53(%>.%]ITYC[2TRG!D M$)'?9S=;IY9H"AZ_QQ+O.OE"W=-(73/+TEU)81F.VFM+E;1[=:4X@GK7'%DY MV>:ZK3`\/##BX?YLN#A0_D'R_P">++S+'BME>7*WDC3=B&'V0, M.:<#';ZF&CPYHY"3<<=?3*7B("Q\L>>M+\FZYIEC:!=2U?49C$XD4!+>8_%* M6'?CVR1R0,@3RB&$-/FABG&(]4YG_2R0UI^67G/RQJ6B:KI$\6HFQ_T:[M8U M6W+VK[OR8_WC5[G)'/"8(.S"&ARXI1E$B7#Z3_#Z%VB_E7YD?1M?2XO[O2[F M[N+B2UM;>8>C*KBJF11_-]DX):B-C:UQ=GY."0)E`R)],3Z6 EX-99.2 4 v407411_ex99-2.htm EXHIBIT 99.2

Exhibit 99.2

	805 King Farm Blvd.
	Rockville, MD 20850 / USA

	Nasdaq.com

By Electronic Delivery to: bing@skystarbio-pharmaceutical.com; aorudjev@schiffhardin.com; scramer@skystarbio-pharmaceutical.com

April 15, 2015

Mr. Bing Mei

Chief Financial Officer

Skystar Bio-Pharmaceutical Company

4/F Building B, Chuangye Square, No. 48 Keji Road

Gaoxin District, Xi’an

Shaanxi Province, P.R. China

Re:

Skystar Bio-Pharmaceutical Company (the “Company”)

Nasdaq Symbol: SKBI

Dear Mr. Mei:

I am following up on my recent telephone conversation with Mr. Scott Cramer in which I explained that since your Company has not yet filed its Form 10-K for the period ended December 31, 2014 (the “Filing”), it no longer complies with our Listing Rules (the “Rules”) for continued listing.¹ Under our Rules the Company now has 60 calendar days to submit a plan to regain compliance and if we accept your plan, we can grant an exception of up to 180 calendar days from the Filing’s due date, or until or until October 12, 2015, to regain compliance. Your plan should be as definitive as possible, addressing any issues that you believe would support your request for an exception. The fee for the compliance plan review is $5,000.2 Please submit your non-refundable Compliance Plan Review fee in accordance with the instructions provided on the attached “Check Payment Form”.

In determining whether to accept your plan, we will consider such things as the likelihood that the Filing, along with any subsequent periodic filing that will be due, can be made within the 180 day period, the Company’s past compliance history, the reasons for the late Filing, other corporate events that may occur within our review period, the Company’s overall financial condition and its public disclosures. Please note that any subsequent periodic filing that is due within the 180 day exception period must be filed no later than the end of the period. Therefore, it would be helpful if your plan addresses each of these points. ³

____________________________

¹ Listing Rule 5250(c)(1). For online access to all Nasdaq Rules, please see “Nasdaq Reference Links,” included with this letter.

² Listing Rule 5810(c)(2).

³ For additional information with respect to compliance plans please see attached “Nasdaq Reference Links” when preparing your plan of compliance. This attachment includes links to the Frequently Asked Questions section relating to continued listing.

Mr. Bing Mei

April 15, 2015

Page 2

Please email your plan and the copy of the Check Payment Form or wire confirmation to me at: moira.keith@nasdaq.com no later than no later than June 15, 2015. After we review the plan, I will contact you if we have any questions or comments and will provide you written notice of our decision. If we do not accept your plan, you will have the opportunity to appeal that decision to a Hearings Panel.⁴

Our Rules require that the Company, as promptly as possible, but no later than four business days from the receipt of this letter, make a public announcement by issuing a press release disclosing receipt of this letter and the Nasdaq Rule(s) upon which it is based.⁵ The Company must also submit the announcement to Nasdaq’s MarketWatch Department.⁶ If the public announcement is made between the hours of 7:00 AM and 8:00 PM Eastern Time, the Company must submit the announcement to Nasdaq’s MarketWatch Department at least ten minutes prior its public release. If the public announcement is made outside of these hours, the Company must submit the announcement prior to 6:50 A.M. Eastern Time. Please note that if you do not make the required announcement trading in your securities will be halted.⁷

In addition, Nasdaq makes available to investors a list of all non-compliant companies, which is posted on our website at https://listingcenter.nasdaq.com. The Company will be included in this list beginning five business days from the date of this letter. As part of this process, an indicator reflecting the Company’s non-compliance will be broadcast over Nasdaq’s market data dissemination network and will also be made available to third party market data providers.

Finally, even though the Company has not filed its periodic report it is still required to provide us with the number of shares issued and outstanding at the end of each quarter. We would appreciate receiving this information electronically via the “Shares Outstanding Change Form,” which can be completed electronically through the NASDAQ OMX Listing Center located at https://listingcenter.nasdaqomx.com. In order to complete the Form, you will need to log in to the Listing Center or create an account, if you do not already have one. Once you are logged in, you will need to enter your CUSIP number to complete your submission. This form should be submitted electronically to us no later than seven days from receipt of this letter. If necessary, the Company may provide us with an estimated number.

____________________________

⁴ See Listing Rule 5815(a).

⁵ Listing Rule 5810(b).

⁶ The notice must be submitted to Nasdaq’s MarketWatch Department through the Electronic Disclosure submission system available at www.NASDAQ.net.

⁷ Listing IM-5810-1.

Mr. Bing Mei

April 15, 2015

Page 3

If you have any questions, please do not hesitate to contact me, at +1 301 978 8052.

Sincerely,

Moira Keith

Associate Director

Nasdaq Listing Qualifications

Enclosures

GRAPHIC 5 image_002.jpg GRAPHIC begin 644 image_002.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`****`"BJM](5A$:,5DD.`5/(QR3_GUK)$-W_S]3_]_#0!T%%<\L%S+>00 M?;;A=S"1L2'[BD$CKWR!^-=#0`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`0W5Y;6,)FN[B&WB!P7E<(N?J:H_\`"3:#_P!!O3?_ M``+C_P`:KWME'JFHRFY"O#`!''&X!&XC+-]>0/P/K47_``CVG?\`/K;_`/?I M:`+O_"2Z#Q_Q.]-YX'^EQ_XUJ`@@$'(/>O%?&HM5UHVD$$(B@4*P5!RQY/\` M2NX\#:YYWA219\L^G@KUY9,97]/E'TKHGAY0IJIW.&CCZ=7$2H+=?CW.D\T7 M-S,`ORPGRPQ[G`)Q^@^H-2;!44,BI$`Y&_J^/[QY--N+R.WMY)3\VU<[1W]O MQZ5SG<+9P+)?2WO4!?(C]L'YC^)P/^`UH5!96WV2RA@SN**`S?WF[G\3DUYW M\2+V^MM8LTM-0O;96@R5M[AXP3N/.%/)K6C2=6?)$Y\3B(X>FZDE='I=%)NFADG?>1D\DJ3W[$>E;/CV>>W\+326]Q-!)YB#S( M9"C#GU'-+V4E4]F]P6*@Z'MUJK7.FHKD_AU=7%WX226[N9KB03RKYD\A=L!C MCD\UO2:UI4+;9=3LD8=FG4'^=1*-FT;0FIQ4EU+U%06U]:7JEK6Z@G`ZF*0- MC\JGI%!15!];TF-RCZI9*XX*M<("/UJW#<0W,?F031RI_>1@P_,4`25!=WEK M80&>\N8;>$'!DFD"+GZFI)9HH(S)-(D:#JSL`!^)KC/'NHZ=?>%Y(H+RUN&\ MU#L217/7K@&KIPYYJ/NDDUK2H6VRZG9(WHTZ@_SJ6K.QI&7-%/N7J*@ MMKVTO5+6MU#.!U,4@;'Y5/2*"BJUSJ-C9MMNKRW@)YQ+*J_S-,BU;39W5(=0 MM)&8X`2922?P-`%RBBB@`IDLJ00O+(P5$&6)["GUBZ_+&XMK!N?/?S''^PG. M?^^ME`''CQ#>1%UC@=E+LVX]6).2:#XGOE4LT#!1US6^+*W_`+HJQ9Z7;7$Q M5D5DVD,/4$8_K5*W4F7-9VW/(+IGN;N:=SEY'+'\3FM7P]>7FGRW/D`M#)&% MD3&02""I^HP?S-7[G1/LUU+"4/R,1TKMBJL/8\J\C MY3*\+66,YY=+W*/]NW__`#P:MCPW/-JVI^7+_VE>:78ZAX;N(#Y#R^:C8_U4JL-P/LPY'N#ZUM1_>N$NL6K^AR8 MK_9HU:;^":;7D^J^>Z/0/`%J+WX?S6C-M6>6XC)QG`+$=*JMX$\):.+]"*I:)J-SIGPIGN+-]DWVJ1`XZJ#)@D>^*J>"O`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`NHPZGX&T6>% ME.VSBCD53G8ZJ%93Z$$&N&UC_DJT?_7[;_\`LE/#5IU)24MK,6886E0ITW36 MO,M;N[_$]:HHHKS3WPKC[V[2XU>[G1E8*1`C#T3.1_WUOKHM8OAIVD7-UN"L MB8CR,Y<\*/Q8@?C7`PF.WA2&($1QJ%4'T'K0!L"YY'/ZUOZ';R1PRSR9!F(V M#/\`"!Q^I/Z5R-H'NKN*!/O.P%>@QQB*)(UZ*H4?A38&9J&BI>W'G*P1B,,, M=:H?\(W<@8%V@'^Z:Z2BFY-I)D1IQBVTMSGH_#LXD4R7:E,\[5YK>AA2W@CA MC&$C4*H]@,4^BI+"N2\5^#YO$5_!)O`W]NZG]NM[I8'=0)0RD[B.`?RX_"NQHJJ=25-\T63B,/ M3Q$.2HKHYK1?"<=CX5DT.^E%Q')([LR#;U;<,>XKF3\.=7TR^FGT+66MA,07 M*RM&7QP-R@%20.^*]+HIJM)7ZW(EA:(]53;J.LQ3- MM*AY79RH/H-HK=\6^"/^$D.GS1W(AN;%"D;Y9#SC.&4@CI78T4W6DVGIIY"C M@Z<5))OWMW?73S/+_P#A77B";;#=:RTD`/26]GE'_?+<'\:[;P]X9LO#L+BW MW232@"25^K8ST'879>0Z>$IPG[35R[MW.$\5?#:TUNX%Y9LD% MR)/-VL2%#]=RE>5.>=!U%UN%>261FCR,;I"XQ[C(_*N87X;ZQ MI-_<7&@ZTUL)V#28E:/?CIN4`J3CO7IM%3&K))K=&L\-"34M4TK73L[=CR_4 MOAYXDUJT>#4=9AE)C9%DD=G*[ACIM%>A7^E6VIZ6UA=KOB90"1P01T(]#5ZB MB564FGM;:P4\+3IJ2WYM[N]SR]_AEJ.F7TTV@ZDUNDQRY2YD@+'_`&@G!/O6 M+%:7ECX\LK:_G\^Z2\@#R;R^[E<Y[;=CS<;@)-0]C=VDM+Z)?,[2BBBN`]HH:MIO]J6J0&7 MRPK[S\N[/!`[^I!_"L<>#U`_X_?_`"%_]E110! GRAPHIC 6 image_003.jpg GRAPHIC begin 644 image_003.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`9+-%`H::5(U)"@NP`)/0W M(=5;J>"J@?>H`W:***`,W7+"6^T_-KL%[;.+BU9S@"1>@)[!@2I/HQJU87D> MH6,-U$"%D7.UNJGNI]P<@^XJQ7.W4G_"/ZS"Z(?L&IW*H_SX$5PW`/T?C_@0 M'=J`.BHHHH`***A-K']L%UF02[/+.)&VEXF2&)<;GD8*!DX')]ZEKG/$6@ZGJMI>?9M8N(V^22TMD"QQB1"&7> MX4O@LO)!&`>AQR`=$K!U#*05(R"#P152\U**RN;.W=)'ENY"D:H!V4L2\@:"Z@BGA;[T-.U>_M(^T+.L\>?^V@ M9@/96`]J`-FL75(;?6[Q=*=/-@A_>7?.`NY&")G^]SOXY&T'C*YE_LN]F^6Z MUFY9.Z0(D6X>[`%A]5(J_:VD%E`(+:)8XQS@=R>I)[D]23R:`*6AW5Q/9R6] MZ0;VSE-O,PZ.0`5?VW(5;'8DCM5+3];DUO5=3MK-S;C3I!%B5`?.;+*S$==F M4*@@@Y5NV*T$TF./Q#-JZRR"2:V2W>+/R':S,&QZ_,1GTK.U+P=I^H:E_:,5 MQ>Z?>'EYK&7RR_UX/H,^N!G.!0!??6[:#17U.X#1PQ$K,,C]VROL;)Z8!!Y] M!6A)(D43R2,%1`68GL!UK+T_P]9:?!Y6^XN1\Q_TF4N#N)+';]W))/.,\GFI M+;0K&U58XEF\A#E(&F=HT]@I.,#L.@XP!@4`.O=6BM]$.J0%)H61'C8MM4AB M,,3CA>2:?-+$;R.1TS""8WVX)P>@8;N5SG@]N:6D%_93V=S&)()XVCD0]&4C!'Y5)%$L,2QH7*J,`NY<_F22:?0!S MHM-2DCM&+`:QIX*+-(K>5=1D`,"P!V[MJDCJK*#A@/FFO+PZAIEUI]S;ZGIT M]Q"\?F0Q,Y3((W*\>X`]QR#["MRB@#`TAM:LM%6*YT\37(W&,"Y!&,DJ'+#Q':R`K+::E!.OWX7L9693]54JP]U)'O6Q10!S46FZ@NK7&LZ M8BVAN`JRV5SPMQMS^\)7/ENHI:**`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/ "_]D_ ` end